Evaluation the effect of dexmedetomidine and remifentanil on posoperative pai
Phase 2
- Conditions
- pain.Generalized pain NOS
- Registration Number
- IRCT20160430027677N13
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age group of 20-60 years old
American Society of Anesthesiologists class I and II
elective lumbar laminectomy
Exclusion Criteria
Patients with hypertension
History of heart disease
Bradycardia (Heart rate less than 50 per minute)
arrhythmia
People who have allergies to drugs used
Gastritis
Renal and pulmonary disease
mental health problems
Drug addict
Patients treated with beta-blockers, methyl dopa, monoamine oxidase inhibitors
Pain medications
Body mass index greater than 25 kg/ m2
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method The average need for an analgesic drug to control pain. Timepoint: In 12 hours after surgery. Method of measurement: milligram.;Mean Arterial Blood Pressure. Timepoint: time of laryngoscopy and during surgery. Method of measurement: None Invasive Blood Pressure.;Mean pulse Rate. Timepoint: time of laryngoscopy and during surgery. Method of measurement: Electrocardiogram.